In this article, published in the Australian Financial Review on the 31st of May 2016, Nick Cameron discusses the significant valuation gap that has emerged between healthcare stocks listed on the ASX, and those listed offshore. With an investment mandate that allows for investment in international shares, Watermark can take advantage of opportunities that emerge in offshore markets and develop a stronger sense of global trends that may manifest in the domestic share market.